| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/07/2007 | CN1302769C Aqueous injection of curcuma oil extract and preparation process and use |
| 03/06/2007 | US7186870 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 03/06/2007 | US7186864 Trifluoromethyl-substituted nitrogen compounds; treating type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumors, and glaucoma |
| 03/06/2007 | US7186849 C7 ester substituted taxanes |
| 03/06/2007 | US7186841 Antiinflammation agents |
| 03/06/2007 | US7186838 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 03/06/2007 | US7186826 Phosphorus-containing compounds and uses thereof |
| 03/06/2007 | US7186825 Polyamines for treatment of diseases such as cancer or treatment of tumors |
| 03/06/2007 | US7186810 Modified peptides as therapeutic agents |
| 03/06/2007 | US7186808 Isolated monoclonal antibody encoded by clone accession number PTA-4889. |
| 03/06/2007 | US7186805 Fusion proteins; for inhibition of cognate receptor |
| 03/06/2007 | US7186804 IL-2 fusion proteins with modulated selectivity |
| 03/06/2007 | US7186803 Human vanilloid receptor VR3 protein |
| 03/06/2007 | US7186802 Membrane proteins; for treatment of inflammation, asthma, allergy, metastasis of cancer cells, ion transport disorders such as magnesium defects in the kidney, and inflammatory bowel disease |
| 03/06/2007 | US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents |
| 03/06/2007 | US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 03/06/2007 | US7186751 anticarcinogenic agents comprising a mixture of taxol, solubilizers, stabilizers and anhydrous ethanol, having superior solubility, stability, bioavailability and side effect reduction |
| 03/06/2007 | US7186748 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 03/06/2007 | US7186745 Angiogenesis inhibitors |
| 03/06/2007 | US7186743 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics |
| 03/06/2007 | US7186737 Inhibitors of p38 |
| 03/06/2007 | US7186723 Tyrosine kinase inhibitors |
| 03/06/2007 | US7186720 Moderator of tumor necrosis factor; antiinflammatory agents; autoimmune diseases |
| 03/06/2007 | US7186718 For therapy of autoimmune, inflammatory, proliferative and hyperproliferative diseases and immunologically-mediated diseases including rejection of transplanted organs or tissues and Acquired Immunodeficiency Syndrome (AIDS |
| 03/06/2007 | US7186717 Pyrrolidine derivatives as Factor Xa inhibitors |
| 03/06/2007 | US7186713 Farnesyl dibenzodiazepinones and methods of treating cancer using same |
| 03/06/2007 | US7186703 Derivatives of branched-chain lipophilic molecules and uses thereof |
| 03/06/2007 | US7186698 Focusing ultrasonic frequency; magnetic resonance imaging |
| 03/06/2007 | US7186697 Delivery system contains a fusion protein having a target moiety and a nucleic acid binding moiety, and a nucleic acid sequence bound to the nucleic acid binding moiety of the fusion protein. The target moiety can be an antibody or a |
| 03/06/2007 | US7186542 Generation and recovering of preferential viral particles; obtain cells, infect with virus, extract virus from cells using detergent, recover virus |
| 03/06/2007 | US7186527 Goodpasture antigen binding protein |
| 03/06/2007 | US7186514 Nucleotide sequences coding tumor marker protein for use in diagnosis and/or prognosis of cell proliferative disorders |
| 03/06/2007 | US7186503 Compounds and methods for modulating activation of NF-κB |
| 03/06/2007 | US7186413 Hydrogels and water soluble polymeric carriers for drug delivery |
| 03/06/2007 | US7186400 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 03/06/2007 | US7186397 Cancer diagnosis; antitumor agents |
| 03/06/2007 | CA2292895C Cyanoguanidines as cell proliferation inhibitors |
| 03/06/2007 | CA2202228C Novel retinoids |
| 03/06/2007 | CA2168319C 4-mercaptobenzoylguanidine derivatives |
| 03/06/2007 | CA2167694C Catharanthus roseus binary alkaloid antimitotic derivatives |
| 03/06/2007 | CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/01/2007 | WO2007025186A2 Hydrazone agents to treat cutaneous lesions |
| 03/01/2007 | WO2007024945A1 Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase |
| 03/01/2007 | WO2007024921A2 Combination therapies for inhibiting integrin-extracellular matrix interactions |
| 03/01/2007 | WO2007024754A1 Bis-aryl urea compounds for the treatment of protein kinase-mediated diseaes |
| 03/01/2007 | WO2007024680A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators |
| 03/01/2007 | WO2007024004A1 Phenylpyridone derivative |
| 03/01/2007 | WO2007023880A1 Chemokine production inhibitor |
| 03/01/2007 | WO2007023815A1 Therapeutic drug for heart disease and virus disease |
| 03/01/2007 | WO2007023778A1 Novel anticancer concomitant drug |
| 03/01/2007 | WO2007023768A1 Novel pyridine derivative and pyrimidine derivative (3) |
| 03/01/2007 | WO2007023766A1 Singlet oxygen generators having silicon-containing substituents |
| 03/01/2007 | WO2007023382A2 Pyrimidine amino pyrazole compounds, potent kinase inhibitors |
| 03/01/2007 | WO2007023307A1 Combinations comprising dmxaa for the treatment of cancer |
| 03/01/2007 | WO2007023302A1 Combinations comprising dmxaa for the treatment of cancer |
| 03/01/2007 | WO2007023298A2 Antibodies |
| 03/01/2007 | WO2007023273A1 Cell migration modulating compounds |
| 03/01/2007 | WO2007023243A2 Cleavage of antifolate compounds |
| 03/01/2007 | WO2007023186A1 Pyrazine derivatives and use as pi3k inhibitors |
| 03/01/2007 | WO2007023182A1 Delta and epsilon crystal forms of imatinib mesylate |
| 03/01/2007 | WO2007022999A1 Polymer conjugates of k-252a and derivatives thereof |
| 03/01/2007 | WO2007022944A1 Solid pharmaceutical composition comprising 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine and a ph modifier |
| 03/01/2007 | WO2007022858A1 3-oxo-indazole-squaric acid derivatives |
| 03/01/2007 | WO2007022824A1 Use of non-steroidal progesterone receptor modulators |
| 03/01/2007 | WO2007022813A2 A METHOD FOR PREPARING A STABLE IMMUNOGENIC PRODUCT COMPRISING ANTIGENIC HETEROCOMPLEXES OF TNFα AND A CARRIER PROTEIN |
| 03/01/2007 | WO2007022635A2 Methods of attenuating prostate tumor growth by insulin-like growth factor binding protein-3 (igfbp-3) |
| 03/01/2007 | WO2007003741A3 Polyphenol type compounds, compositions containing same and use thereof for preventing or treating diseases involving abnormal cell proliferation |
| 03/01/2007 | WO2007002722A3 Synthesis of anastrozole and purification of one of its intermediate |
| 03/01/2007 | WO2006138347A3 Androgen receptor modulator compounds and methods |
| 03/01/2007 | WO2006122186A3 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia |
| 03/01/2007 | WO2006114520A3 Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof |
| 03/01/2007 | WO2006105507A3 Indoloquinone tumor radiation sensitization |
| 03/01/2007 | WO2006103187A3 Method for administration of capecitabine |
| 03/01/2007 | WO2006086730A3 Inhibiting her2 shedding with matrix metalloprotease antagonists |
| 03/01/2007 | WO2006085219A3 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy |
| 03/01/2007 | WO2006077146A3 Method for producing albumin conjugates containing gyrase inhibitors |
| 03/01/2007 | WO2006018501A8 Galenic applications of self-emulsifying mixtures of lipidic excipients |
| 03/01/2007 | WO2006014325A3 C-met modulators and method of use |
| 03/01/2007 | WO2005105098A3 Preparation for the treatment of cancer |
| 03/01/2007 | US20070049735 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070049620 Cyclic tertiary amine compound |
| 03/01/2007 | US20070049600 Pteridinones as kinase inhibitors |
| 03/01/2007 | US20070049566 Methods and Compositions for inhibition of angiogenesis |
| 03/01/2007 | US20070049558 New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors |
| 03/01/2007 | US20070049544 Antisense IAP nucleobase oligomers and uses thereof |
| 03/01/2007 | US20070049540 Oligonucleotide inhibiting the expression of star-binding protein (sbp) gene and method therefor |
| 03/01/2007 | US20070049532 Selecting by phage display a peptide that binds to nerve growth factor (NGF), and preparing a fusion protein with an Fc domain; biological half-life increases |
| 03/01/2007 | US20070048846 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048809 Using monoclonal antibody NUH2 as diagnositic tool in identifying cell proliferative disorders of urogenital system in individual negative for prostate specific antigen |
| 03/01/2007 | US20070048804 Methods of detecting cytokine receptor zcytor19 ligand |
| 03/01/2007 | US20070048799 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs |
| 03/01/2007 | US20070048782 Methods for assessing and treating leukemia |
| 03/01/2007 | US20070048390 Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases |
| 03/01/2007 | US20070048363 chemotherapeutical agent comprising cis-diammoniumdichloro-trans-dihydroxoplatinum(IV) or salts and/or derivatives thereof in the form of capsules, tablets, creams, ointments and infusion solutions; antitumor agents |
| 03/01/2007 | US20070048326 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 03/01/2007 | US20070048319 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048305 CD147 binding molecules as therapeutics |
| 03/01/2007 | US20070048299 Methods of inducing an immune response |
| 03/01/2007 | US20070048287 Molecular antigen array |
| 03/01/2007 | US20070048283 Exposing to immunogenic portion of protein and/or encoding nucleotide homologenous to sequence 20 or 22b; eliciting response to 74P3B3 protein; pancreatic cancer |